-
XTANDI® treatment granted priority review by FDA
europeanpharmaceuticalreview
August 27, 2019
XTANDI® sNDA seeks to add an indication for men with prostate cancer that’s spread but is sensitive to hormone therapy.
-
Cervical cancer vaccine market set to increase at 12.1 percent CAGR
europeanpharmaceuticalreview
August 27, 2019
A recent report has predicted that the cervical cancer vaccine market will increase to $6b by the end of the forecast period.
-
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors
drugs
August 27, 2019
Survivors of childhood cancer have an increased risk for all subtypes of cardiovascular disease (CVD), according to a research letter published online Aug. 26 in Circulation.
-
Childhood Cancer Survivors Struggle With Heart Troubles
drugs
August 27, 2019
The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds.
-
Men Should Be Included in Breast Cancer Clinical Trials
drugs
August 27, 2019
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.
-
Imfinzi combination fails advanced lung cancer study
europeanpharmaceuticalreview
August 23, 2019
A late-stage clinical trial for Imfinzi and an experimental treatment has not extended the lives of patients with advanced non-small cell lung cancer.
-
Preventing tumor metastasis
worldpharmanews
August 23, 2019
Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG...
-
More Antibiotics, Higher Odds for Colon Cancer?
drugs
August 22, 2019
Taking certain antibiotics -- especially multiple times or for long courses -- may put you at risk for colon cancer, a large new study suggests.
-
Selinexor Offers Hope Against a Tough-to-Treat Blood Cancer
drugs
August 22, 2019
Patients with a form of blood cancer known as multiple myeloma who haven't responded to other therapies might have a new weapon against the disease, researchers say.
-
Oral Antibiotic Use Linked to Risk for Colorectal Cancer
drugs
August 22, 2019
Oral antibiotic use is associated with an increased risk for colon cancer and a reduced risk for rectal cancer, according to a study published online in Gut.